Walgreen's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Walgreen (WAG)

Q2 2012 Earnings Call

March 27, 2012 8:30 am ET

Executives

Rick J. Hans - Divisional Vice President of Investor Relations & Finance and Assistant Treasurer

Gregory D. Wasson - Chief Executive Officer, President and Director

Wade D. Miquelon - Chief Financial Officer and Executive Vice President

Kermit R. Crawford - President of Pharmacy, Health, Wellness Services & Solutions

Analysts

Andrew P. Wolf - BB&T Capital Markets, Research Division

Ann K. Hynes - Mizuho Securities USA Inc., Research Division

Mark R. Miller - William Blair & Company L.L.C., Research Division

Thomas Gallucci - Lazard Capital Markets LLC, Research Division

Matthew J. Fassler - Goldman Sachs Group Inc., Research Division

Scott Andrew Mushkin - Jefferies & Company, Inc., Research Division

John Heinbockel - Guggenheim Securities, LLC, Research Division

David G. Magee - SunTrust Robinson Humphrey, Inc., Research Division

Presentation

Operator

Good day, and welcome to the Walgreen Co. Second Quarter 2012 Earnings Conference Call. At this time, I would like to turn the conference over to your host, Divisional Vice President of Investor Relations, Rick Hans. You may begin.

Rick J. Hans

Thank you. Good morning, everyone. Welcome to our second quarter conference call. Today, Greg Wasson, President and CEO; and Wade Miquelon, Executive Vice President and CFO, will update you on the quarter. Also joining us on the call and available for questions is Kermit Crawford, President of Pharmacy, and Mark Wagner, President of Community Management.

As a reminder, today's presentation includes certain non-GAAP financial measures, and I would direct you to our web website at investor.walgreens.com for reconciliation.

If you liked this article you might like

Cramer: Dominoes Are in Play Today

In Case You Missed It Weekend Edition: National Enquirer Trumps Energy Week

Former Walmart Exec Says Border Tax Opposed by Retailers Could Save Industry

Walgreen Looks Good However Rite-Aid Deal Pans Out